1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Research and Development Analysis & Statistics, September 2016

Research and Development Analysis & Statistics, September 2016

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

1-30 of about 1 900 reports

Purchase Reports From Reputable Market Research Publishers

Analysis of the Asia-Pacific Network Security Market 2015

Analysis of the Asia-Pacific Network Security Market 2015

  • $ 20 000
  • Industry report
  • July 2016
  • by Frost & Sullivan

Critical Infrastructure Protection Drives New Demands for Security Solutions Scope of the report The research report includes the following segments: Product scope: Network Security Technologies. Sub-segments ...

  • Industries : Research and Development
  • Countries : Asia
Respiratory Care Devices Global Market - Forecast to 2022

Respiratory Care Devices Global Market - Forecast to 2022

  • $ 4 500
  • Industry report
  • August 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Respiratory Care Diagnostic devices are the devices which are used for the diagnosis of respiratory diseases such as Pneumonia, Asthma, Bronchitis, Sleep Apnea, cystic and pulmonary fibrosis, Tuberculosis, ...

  • Industries : Medical Device, Respiratory Device
  • Countries : World
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC ...

  • Industries : Therapy, Biopharmaceutical, Biotechnology, Pharmaceutical, Biological Therapy
  • Countries : United States
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

  • Industries : Research and Development
  • Countries : World
E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2016

E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘E3 ...

  • Industries : Biopharmaceutical, Cancer, Pathology, Therapy
  • Countries : United States, World
Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeli

Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeli

  • $ 3 500
  • Industry report
  • July 2016
  • by Global Markets Direct

Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR ...

  • Industries : Cancer, Pathology, Pharmaceutical, Therapy
  • Countries : United States
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2016

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cyclin Dependent Kinase 4 (Cell Division Protein ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States
Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016

Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Alpha-Synuclein (alphaSyn or SNCA) - Pipeline Review, H1 2016’, provides in depth analysis on Alpha-Synuclein ...

  • Industries : Mental Health, Pathology, Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States, World
Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States
Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016

Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016’, provides in depth analysis on Toll ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2016

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 ...

  • Industries : Mental Health, Pharmaceutical, Pathology, Therapy
  • Countries : United States
Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016

Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Telomerase ...

  • Industries : Cancer, Pathology, Therapy, Biotechnology, Biopharmaceutical
  • Countries : United States, World
Global Molecular Diagnostics 2010-2016: Deal trends, players, financials and forecasts

Global Molecular Diagnostics 2010-2016: Deal trends, players, financials and forecasts

  • $ 2 995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Molecular Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be ...

  • Industries : Healthcare, Pathology, Diagnostics, Genomics, Cancer, Biotechnology, General Medicine and Specialty Medicine
  • Countries : United States
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2016

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2016

  • $ 2 995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the collaborative R&D deals ...

  • Industries : Research and Development
  • Countries : United States
Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2016

Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2016

  • $ 2 995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered ...

  • Industries : Genomics, Drug Discovery and Development, Biotechnology
  • Countries : United States
Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016

  • $ 2 995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering ...

  • Industries : Healthcare, Cancer, Pathology, Genomics, Biotechnology, Medical Facility, Pharmaceutical, General Medicine and Specialty Medicine, Therapy, Diagnostics
  • Countries : United States
Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

  • $ 2 995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical, Pathology, Therapy, Cancer, Healthcare
  • Countries : United States
Alzheimer%s Disease - Pipeline Review, H2 2016

Alzheimer%s Disease - Pipeline Review, H2 2016

  • $ 2 500
  • Company report
  • August 2016
  • by Global Markets Direct

Alzheimer's Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape. ...

  • Industries : Pathology, Mental Health
  • Countries : United States
Global Research and Development Spending in the Robotics Industry 2016-2020

Global Research and Development Spending in the Robotics Industry 2016-2020

  • $ 2 500
  • Industry report
  • July 2016
  • by Infiniti Research Limited

About the R&D activities in robotics technologies The robotics market is witnessing a major makeover in terms of investments for both R&D activities and product development both through vendor CAPEX and ...

  • Industries : Industrial Equipment, Research and Development, Manufacturing
  • Countries : Europe, World, United States, China, Japan
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, ...

  • Industries : Cancer, Pathology
  • Countries : United States
Melanoma - Pipeline Review, H1 2016

Melanoma - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Melanoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape. The report provides comprehensive ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Colorectal Cancer - Pipeline Review, H1 2016

Colorectal Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Colorectal Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape. The ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
HIV / AIDS - Pipeline Review, H1 2016

HIV / AIDS - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

HIV / AIDS - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2016’, provides an overview of the HIV / AIDS pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Healthcare, Biotechnology, Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Non-Small Cell Lung Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cance ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Prostate Cancer - Pipeline Review, H1 2016

Prostate Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape. The report ...

  • Industries : Cancer, Pathology
  • Countries : United States
Parkinson%s Disease - Pipeline Review, H1 2016

Parkinson%s Disease - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Parkinson's Disease - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2016’, provides an overview of the Parkinson's Disease pipeline landscape. ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World
Ovarian Cancer - Pipeline Review, H1 2016

Ovarian Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape. The report provides ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Rheumatoid Arthritis - Pipeline Review, H1 2016

Rheumatoid Arthritis - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape. ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States, World
Pancreatic Cancer - Pipeline Review, H1 2016

Pancreatic Cancer - Pipeline Review, H1 2016

  • $ 2 500
  • Company report
  • June 2016
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape. The ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America
Epilepsy - Pipeline Review, H2 2016

Epilepsy - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • August 2016
  • by Global Markets Direct

Epilepsy - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2016’, provides an overview of the Epilepsy pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Mental Health, General Medicine and Specialty Medicine, Healthcare, Pharmaceutical
  • Countries : United States
About 6 200 reports

Download Unlimited Documents from Trusted Public Sources

R&D Supply in Canada

  • September 2016
    5 pages
  • R-and-D  

    Software  

  • Canada  

View report >

R&d Industry In The Uk

September 2016

Us - Economic Analysis

September 2016

R&d Industry In The Uk

September 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.